Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Lewin

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Epidemiology|December 22, 2020
Sarcoma incidence and subtype distribution in Israel - A population-based studyOded Icht, Ron Lewin, Lilach Yosef, et al.
Journal of Cancer Research and Therapeutics|March 30, 2024
Postoperative chemoradiotherapy in patients with locally advanced gastric cancer with poor pathologic response to neoadjuvant chemotherapyOmer Gal, Ron Lewin, Gali Perl, et al.
International Journal of Environmental Research and Public Health|January 8, 2023
The Utility of 68Ga-PSMA PET/CT in Decisions Regarding Administering Salvage Radiotherapy to Men with Prostate CancerJennifer Ben Shimol, Ron Lewin, Zvi Symon, et al.
American Journal of Clinical Oncology|February 18, 2025
Effect of Continuous Nutritionist-led Guidance on Bowel Preparation in Patients Undergoing Prostate Stereotactic Body Radiation Treatment With Endorectal Spacing: A Prospective Pilot TrialYonatan Carmeli, Yael Shpatz, Iris Oren-Ivry, et al.
American Journal of Clinical Oncology|April 30, 2021
Is Ultra Hypofractionated Radiation Therapy a Safe and Effective Treatment for Invasive Bladder Cancer in the Elderly?: A Retrospective Single Institution ReviewNoam Symon, Jacoubo Mattout, Ron Lewin, et al.
Radiation Oncology (London, England)|June 24, 2021
Salvage re-irradiation using stereotactic body radiation therapy for locally recurrent prostate cancer: the impact of castration sensitivity on treatment outcomesRon Lewin, Uri Amit, Menachem Laufer, et al.
Breast Cancer Research and Treatment|April 3, 2024
BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterizationRinat Yerushalmi, Adi Pomerantz, Ron Lewin, et al.
Cancer Medicine|October 24, 2018
Early PET-CT in patients with pathological stage III colon cancer may improve their outcome: Results from a large retrospective studyAssaf Moore, Olga Ulitsky, Irit Ben-Aharon, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Epidemiology|December 22, 2020
Sarcoma incidence and subtype distribution in Israel - A population-based studyOded Icht, Ron Lewin, Lilach Yosef, et al.
Journal of Cancer Research and Therapeutics|March 30, 2024
Postoperative chemoradiotherapy in patients with locally advanced gastric cancer with poor pathologic response to neoadjuvant chemotherapyOmer Gal, Ron Lewin, Gali Perl, et al.
International Journal of Environmental Research and Public Health|January 8, 2023
The Utility of 68Ga-PSMA PET/CT in Decisions Regarding Administering Salvage Radiotherapy to Men with Prostate CancerJennifer Ben Shimol, Ron Lewin, Zvi Symon, et al.
American Journal of Clinical Oncology|February 18, 2025
Effect of Continuous Nutritionist-led Guidance on Bowel Preparation in Patients Undergoing Prostate Stereotactic Body Radiation Treatment With Endorectal Spacing: A Prospective Pilot TrialYonatan Carmeli, Yael Shpatz, Iris Oren-Ivry, et al.
American Journal of Clinical Oncology|April 30, 2021
Is Ultra Hypofractionated Radiation Therapy a Safe and Effective Treatment for Invasive Bladder Cancer in the Elderly?: A Retrospective Single Institution ReviewNoam Symon, Jacoubo Mattout, Ron Lewin, et al.
Radiation Oncology (London, England)|June 24, 2021
Salvage re-irradiation using stereotactic body radiation therapy for locally recurrent prostate cancer: the impact of castration sensitivity on treatment outcomesRon Lewin, Uri Amit, Menachem Laufer, et al.
Breast Cancer Research and Treatment|April 3, 2024
BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterizationRinat Yerushalmi, Adi Pomerantz, Ron Lewin, et al.
Cancer Medicine|October 24, 2018
Early PET-CT in patients with pathological stage III colon cancer may improve their outcome: Results from a large retrospective studyAssaf Moore, Olga Ulitsky, Irit Ben-Aharon, et al.
Pageof 1